SANCHEZ, YAMILA; VASQUEZ, ABIGAIL; MIRET, NOELIA; ROLANDELLI, GABINO; COSTAS, CATALINA; RANDI, ANDREA; ESPAÑOL, ALEJANDRO

Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells

Exploration of Targeted Anti-tumor Therapy; Año: 2023

ESPAÑOL, ALEJANDRO; SANCHEZ, YAMILA; OBREGÓN, JAQUELINE; SALEM, AGUSTINA; SALES, MARÍA ELENA

Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells

World Journal of Clinical Oncology; Lugar: Pleasanton; Año: 2022

ESPAÑOL, ALEJANDRO; SALEM, AGUSTINA; SANCHEZ, YAMILA; SALES, MARÍA ELENA

Breast cancer: Muscarinic receptors as new targets for tumor therapy

World Journal of Clinical Oncology; Año: 2021 vol. 12 p. 404 - 428

ESPAÑOL A; SALEM A; DI BARI, M; CRISTOFARO, I; SANCHEZ Y; TATA A M; SALES ME

The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype

PLOS ONE; Lugar: San Francisco; Año: 2020

SALEM A; MARTINEZ PULIDO P; SANCHEZ F; SANCHEZ Y; ESPAÑOL A; SALES ME

Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors

INTERNATIONAL IMMUNOPHARMACOLOGY; Lugar: Amsterdam; Año: 2020

SALES, MARÍA ELENA; ESPAÑOL A; SALEM A; MARTINEZ PULIDO P; SANCHEZ Y; SANCHEZ F

Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy

Current Clinical Pharmacology; Año: 2018